In the present study, a concomitant downregulation of miR-486 and an upregulation of mRNA expression of ARHGAP5 suggests a pathogenic role of miR-486 in CLL. This evidence concerns the gene ARHGAP5 and B-cell chronic lymphocytic leukemia.